Updated Jul 16, 2026
Shah Rutul R has filed 4 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $7K. Lifetime open-market sales: $437K.
Rutul R. Shah is the Chief Operating Officer of Precigen, Inc., a biotechnology company focused on developing and commercializing innovative gene and cell therapies. His role involves overseeing the company's operational strategies and execution.
| Role | Chief Operating Officer |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 42.9K | $5.85 | $251K |
| 2026-07-01 | PGEN | PRECIGEN, INC. | M — Option exercise | 42.9K | $2.33 | $100K |
| 2026-06-01 | PGEN | PRECIGEN, INC. | S — Open-market sale | 42.7K | $4.36 | $186K |
| 2026-05-28 | PGEN | PRECIGEN, INC. | M — Option exercise | 90.0K | — | |
| 2026-03-20 | PGEN | PRECIGEN, INC. | M — Option exercise | 44.5K | — | |
| 2025-09-26 | PGEN | PRECIGEN, INC. | P — Open-market purchase | 2.0K | $3.40 | $7K |
Rutul R. Shah is the Chief Operating Officer of Precigen, Inc., a biotechnology company focused on developing and commercializing innovative gene and cell therapies. His role involves overseeing the company's operational strategies and execution.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($7K) and 2 open-market sales ($437K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shah Rutul R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.